HEADER HYDROLASE 22-MAR-20 7BPI TITLE THE CRYSTAL STRUCTUE OF PDE10A COMPLEXED WITH 14 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAMP AND CAMP-INHIBITED CGMP 3',5'-CYCLIC PHOSPHODIESTERASE COMPND 3 10A; COMPND 4 CHAIN: A, B; COMPND 5 EC: 3.1.4.17,3.1.4.35; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PDE10A; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 KEYWDS PDE10A INHIBITOR, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR Y.YANG,S.ZHANG,Q.ZHOU,Y.-Y.HUANG,L.GUO,H.-B.LUO REVDAT 2 29-NOV-23 7BPI 1 REMARK REVDAT 1 27-JAN-21 7BPI 0 JRNL AUTH Y.YANG,S.ZHANG,Q.ZHOU,C.ZHANG,Y.GAO,H.WANG,Z.LI,D.WU,Y.WU, JRNL AUTH 2 Y.Y.HUANG,L.GUO,H.B.LUO JRNL TITL DISCOVERY OF HIGHLY SELECTIVE AND ORALLY AVAILABLE JRNL TITL 2 BENZIMIDAZOLE-BASED PHOSPHODIESTERASE 10 INHIBITORS WITH JRNL TITL 3 IMPROVED SOLUBILITY AND PHARMACOKINETIC PROPERTIES FOR JRNL TITL 4 TREATMENT OF PULMONARY ARTERIAL HYPERTENSION. JRNL REF ACTA PHARM SIN B V. 10 2339 2020 JRNL REFN ISSN 2211-3835 JRNL PMID 33354505 JRNL DOI 10.1016/J.APSB.2020.04.003 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10_2155 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.26 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 2.023 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 3 NUMBER OF REFLECTIONS : 26047 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.256 REMARK 3 R VALUE (WORKING SET) : 0.252 REMARK 3 FREE R VALUE : 0.326 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 1305 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 19.2550 - 4.9669 0.91 2715 148 0.1855 0.2357 REMARK 3 2 4.9669 - 3.9535 0.95 2729 147 0.2025 0.2933 REMARK 3 3 3.9535 - 3.4571 0.97 2733 152 0.2308 0.3085 REMARK 3 4 3.4571 - 3.1425 0.99 2737 149 0.2641 0.3371 REMARK 3 5 3.1425 - 2.9181 0.99 2782 154 0.2888 0.3893 REMARK 3 6 2.9181 - 2.7465 0.99 2781 136 0.2932 0.3487 REMARK 3 7 2.7465 - 2.6093 0.99 2785 127 0.3079 0.3616 REMARK 3 8 2.6093 - 2.4960 1.00 2761 136 0.3116 0.4174 REMARK 3 9 2.4960 - 2.4001 0.99 2719 156 0.3461 0.4127 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.510 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 33.742 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.69 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.82 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 5247 REMARK 3 ANGLE : 1.111 7109 REMARK 3 CHIRALITY : 0.056 779 REMARK 3 PLANARITY : 0.009 936 REMARK 3 DIHEDRAL : 17.318 3132 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7BPI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 27-MAR-20. REMARK 100 THE DEPOSITION ID IS D_1300016259. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-MAR-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : SEALED TUBE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : OXFORD DIFFRACTION NOVA REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5405 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : OXFORD ONYX CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSALISPRO 38.41 REMARK 200 DATA SCALING SOFTWARE : CRYSALISPRO 38.41 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26047 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 19.260 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.11000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.37700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 1.10 REMARK 200 STARTING MODEL: 2OUP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.64 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES (PH 7.5), 0.2 M MGCL2, 18% REMARK 280 PEG 3350, 50 MM 2-MERCAPTOETHANOL, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.97050 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 81.24650 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.84150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 81.24650 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.97050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 40.84150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 240 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14180 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -49.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 220 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14630 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -49.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 449 REMARK 465 ILE A 450 REMARK 465 CYS A 451 REMARK 465 THR A 452 REMARK 465 SER A 453 REMARK 465 GLU A 454 REMARK 465 GLU A 455 REMARK 465 TRP A 456 REMARK 465 GLN A 457 REMARK 465 GLU A 770 REMARK 465 GLY B 768 REMARK 465 GLU B 769 REMARK 465 GLU B 770 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 461 CG CD OE1 NE2 REMARK 470 SER A 501 OG REMARK 470 SER A 616 OG REMARK 470 GLN A 650 CG CD OE1 NE2 REMARK 470 ASN A 657 CG OD1 ND2 REMARK 470 ILE A 708 CG1 CG2 CD1 REMARK 470 GLN A 724 CG CD OE1 NE2 REMARK 470 PHE B 578 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ASP B 579 CG OD1 OD2 REMARK 470 GLU B 702 CG CD OE1 OE2 REMARK 470 LEU B 706 CG CD1 CD2 REMARK 470 ILE B 708 CG1 CG2 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 922 O HOH B 947 1.84 REMARK 500 N SER B 449 O HOH B 901 1.92 REMARK 500 NH1 ARG B 642 O HOH B 902 1.96 REMARK 500 O GLY A 458 O HOH A 901 1.98 REMARK 500 OE1 GLU A 763 O HOH A 902 2.02 REMARK 500 OE1 GLU B 618 O HOH B 903 2.05 REMARK 500 OE2 GLU B 504 O HOH B 904 2.08 REMARK 500 O ALA A 632 O HOH A 903 2.09 REMARK 500 OG1 THR A 651 OG SER A 653 2.10 REMARK 500 O GLU A 473 O HOH A 904 2.10 REMARK 500 NE2 GLN B 461 O HOH B 905 2.11 REMARK 500 O VAL B 491 O HOH B 906 2.11 REMARK 500 O ILE B 450 O HOH B 907 2.11 REMARK 500 OE2 GLU A 483 O HOH A 905 2.11 REMARK 500 O HOH A 961 O HOH A 964 2.12 REMARK 500 O VAL A 522 O HOH A 906 2.12 REMARK 500 N TRP B 682 O HOH B 908 2.14 REMARK 500 O HOH A 944 O HOH A 962 2.17 REMARK 500 OE2 GLU A 473 O HOH A 907 2.18 REMARK 500 ND2 ASN A 526 O HOH A 906 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 477 135.91 -33.73 REMARK 500 ARG A 521 49.45 -86.40 REMARK 500 ASN A 526 -162.81 -110.79 REMARK 500 ASN A 544 32.39 -145.11 REMARK 500 THR A 549 -177.25 -62.65 REMARK 500 LEU A 706 40.85 -96.34 REMARK 500 LYS A 719 -36.74 -34.30 REMARK 500 VAL A 733 -52.92 -128.63 REMARK 500 THR A 748 42.57 -98.95 REMARK 500 SER B 453 -52.69 -27.99 REMARK 500 TYR B 524 -57.09 -121.30 REMARK 500 ASN B 544 47.20 -146.44 REMARK 500 THR B 546 5.86 -69.41 REMARK 500 ASP B 579 47.81 26.26 REMARK 500 ASN B 609 96.20 -67.20 REMARK 500 THR B 613 2.68 -66.94 REMARK 500 LEU B 654 105.24 -53.18 REMARK 500 VAL B 733 -68.95 -134.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASN A 544 HIS A 545 -148.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 967 DISTANCE = 6.31 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 801 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 529 NE2 REMARK 620 2 HIS A 563 NE2 86.8 REMARK 620 3 ASP A 564 OD2 89.7 70.8 REMARK 620 4 ASP A 674 OD1 80.3 89.3 158.3 REMARK 620 5 HOH A 926 O 151.2 121.3 93.9 104.2 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 802 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 564 OD1 REMARK 620 2 HOH A 918 O 86.1 REMARK 620 3 HOH A 926 O 71.8 89.0 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 801 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 529 NE2 REMARK 620 2 HIS B 563 NE2 84.9 REMARK 620 3 ASP B 564 OD2 106.3 85.9 REMARK 620 4 ASP B 674 OD2 80.5 75.8 160.0 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 802 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 564 OD1 REMARK 620 2 GLU B 592 OE2 123.8 REMARK 620 3 HOH B 916 O 64.6 68.9 REMARK 620 N 1 2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZN A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MG A 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DZU A 803 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZN B 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MG B 802 DBREF 7BPI A 449 770 UNP Q9Y233 PDE10_HUMAN 439 760 DBREF 7BPI B 449 770 UNP Q9Y233 PDE10_HUMAN 439 760 SEQRES 1 A 322 SER ILE CYS THR SER GLU GLU TRP GLN GLY LEU MET GLN SEQRES 2 A 322 PHE THR LEU PRO VAL ARG LEU CYS LYS GLU ILE GLU LEU SEQRES 3 A 322 PHE HIS PHE ASP ILE GLY PRO PHE GLU ASN MET TRP PRO SEQRES 4 A 322 GLY ILE PHE VAL TYR MET VAL HIS ARG SER CYS GLY THR SEQRES 5 A 322 SER CYS PHE GLU LEU GLU LYS LEU CYS ARG PHE ILE MET SEQRES 6 A 322 SER VAL LYS LYS ASN TYR ARG ARG VAL PRO TYR HIS ASN SEQRES 7 A 322 TRP LYS HIS ALA VAL THR VAL ALA HIS CYS MET TYR ALA SEQRES 8 A 322 ILE LEU GLN ASN ASN HIS THR LEU PHE THR ASP LEU GLU SEQRES 9 A 322 ARG LYS GLY LEU LEU ILE ALA CYS LEU CYS HIS ASP LEU SEQRES 10 A 322 ASP HIS ARG GLY PHE SER ASN SER TYR LEU GLN LYS PHE SEQRES 11 A 322 ASP HIS PRO LEU ALA ALA LEU TYR SER THR SER THR MET SEQRES 12 A 322 GLU GLN HIS HIS PHE SER GLN THR VAL SER ILE LEU GLN SEQRES 13 A 322 LEU GLU GLY HIS ASN ILE PHE SER THR LEU SER SER SER SEQRES 14 A 322 GLU TYR GLU GLN VAL LEU GLU ILE ILE ARG LYS ALA ILE SEQRES 15 A 322 ILE ALA THR ASP LEU ALA LEU TYR PHE GLY ASN ARG LYS SEQRES 16 A 322 GLN LEU GLU GLU MET TYR GLN THR GLY SER LEU ASN LEU SEQRES 17 A 322 ASN ASN GLN SER HIS ARG ASP ARG VAL ILE GLY LEU MET SEQRES 18 A 322 MET THR ALA CYS ASP LEU CYS SER VAL THR LYS LEU TRP SEQRES 19 A 322 PRO VAL THR LYS LEU THR ALA ASN ASP ILE TYR ALA GLU SEQRES 20 A 322 PHE TRP ALA GLU GLY ASP GLU MET LYS LYS LEU GLY ILE SEQRES 21 A 322 GLN PRO ILE PRO MET MET ASP ARG ASP LYS LYS ASP GLU SEQRES 22 A 322 VAL PRO GLN GLY GLN LEU GLY PHE TYR ASN ALA VAL ALA SEQRES 23 A 322 ILE PRO CYS TYR THR THR LEU THR GLN ILE LEU PRO PRO SEQRES 24 A 322 THR GLU PRO LEU LEU LYS ALA CYS ARG ASP ASN LEU SER SEQRES 25 A 322 GLN TRP GLU LYS VAL ILE ARG GLY GLU GLU SEQRES 1 B 322 SER ILE CYS THR SER GLU GLU TRP GLN GLY LEU MET GLN SEQRES 2 B 322 PHE THR LEU PRO VAL ARG LEU CYS LYS GLU ILE GLU LEU SEQRES 3 B 322 PHE HIS PHE ASP ILE GLY PRO PHE GLU ASN MET TRP PRO SEQRES 4 B 322 GLY ILE PHE VAL TYR MET VAL HIS ARG SER CYS GLY THR SEQRES 5 B 322 SER CYS PHE GLU LEU GLU LYS LEU CYS ARG PHE ILE MET SEQRES 6 B 322 SER VAL LYS LYS ASN TYR ARG ARG VAL PRO TYR HIS ASN SEQRES 7 B 322 TRP LYS HIS ALA VAL THR VAL ALA HIS CYS MET TYR ALA SEQRES 8 B 322 ILE LEU GLN ASN ASN HIS THR LEU PHE THR ASP LEU GLU SEQRES 9 B 322 ARG LYS GLY LEU LEU ILE ALA CYS LEU CYS HIS ASP LEU SEQRES 10 B 322 ASP HIS ARG GLY PHE SER ASN SER TYR LEU GLN LYS PHE SEQRES 11 B 322 ASP HIS PRO LEU ALA ALA LEU TYR SER THR SER THR MET SEQRES 12 B 322 GLU GLN HIS HIS PHE SER GLN THR VAL SER ILE LEU GLN SEQRES 13 B 322 LEU GLU GLY HIS ASN ILE PHE SER THR LEU SER SER SER SEQRES 14 B 322 GLU TYR GLU GLN VAL LEU GLU ILE ILE ARG LYS ALA ILE SEQRES 15 B 322 ILE ALA THR ASP LEU ALA LEU TYR PHE GLY ASN ARG LYS SEQRES 16 B 322 GLN LEU GLU GLU MET TYR GLN THR GLY SER LEU ASN LEU SEQRES 17 B 322 ASN ASN GLN SER HIS ARG ASP ARG VAL ILE GLY LEU MET SEQRES 18 B 322 MET THR ALA CYS ASP LEU CYS SER VAL THR LYS LEU TRP SEQRES 19 B 322 PRO VAL THR LYS LEU THR ALA ASN ASP ILE TYR ALA GLU SEQRES 20 B 322 PHE TRP ALA GLU GLY ASP GLU MET LYS LYS LEU GLY ILE SEQRES 21 B 322 GLN PRO ILE PRO MET MET ASP ARG ASP LYS LYS ASP GLU SEQRES 22 B 322 VAL PRO GLN GLY GLN LEU GLY PHE TYR ASN ALA VAL ALA SEQRES 23 B 322 ILE PRO CYS TYR THR THR LEU THR GLN ILE LEU PRO PRO SEQRES 24 B 322 THR GLU PRO LEU LEU LYS ALA CYS ARG ASP ASN LEU SER SEQRES 25 B 322 GLN TRP GLU LYS VAL ILE ARG GLY GLU GLU HET ZN A 801 1 HET MG A 802 1 HET DZU A 803 39 HET ZN B 801 1 HET MG B 802 1 HETNAM ZN ZINC ION HETNAM MG MAGNESIUM ION HETNAM DZU 8-[(E)-2-[5-METHYL-1-[3-[3-(4-METHYLPIPERAZIN-1-YL) HETNAM 2 DZU PROPOXY]PHENYL]BENZIMIDAZOL-2-YL]ETHENYL]QUINOLINE FORMUL 3 ZN 2(ZN 2+) FORMUL 4 MG 2(MG 2+) FORMUL 5 DZU C33 H35 N5 O FORMUL 8 HOH *118(H2 O) HELIX 1 AA1 ARG A 467 ILE A 472 1 6 HELIX 2 AA2 PHE A 482 ASN A 484 5 3 HELIX 3 AA3 MET A 485 CYS A 498 1 14 HELIX 4 AA4 GLU A 504 ASN A 518 1 15 HELIX 5 AA5 ASN A 526 ASN A 543 1 18 HELIX 6 AA6 THR A 549 HIS A 563 1 15 HELIX 7 AA7 SER A 571 PHE A 578 1 8 HELIX 8 AA8 PRO A 581 TYR A 586 1 6 HELIX 9 AA9 SER A 589 GLN A 604 1 16 HELIX 10 AB1 SER A 615 THR A 633 1 19 HELIX 11 AB2 ASP A 634 THR A 651 1 18 HELIX 12 AB3 ASN A 658 CYS A 676 1 19 HELIX 13 AB4 SER A 677 LYS A 680 5 4 HELIX 14 AB5 LEU A 681 LEU A 706 1 26 HELIX 15 AB6 ILE A 711 ASP A 720 5 10 HELIX 16 AB7 GLU A 721 VAL A 733 1 13 HELIX 17 AB8 VAL A 733 LEU A 745 1 13 HELIX 18 AB9 THR A 748 GLY A 768 1 21 HELIX 19 AC1 THR B 452 PHE B 462 1 11 HELIX 20 AC2 PRO B 465 ILE B 472 1 8 HELIX 21 AC3 PHE B 482 ASN B 484 5 3 HELIX 22 AC4 MET B 485 CYS B 498 1 14 HELIX 23 AC5 GLU B 504 ASN B 518 1 15 HELIX 24 AC6 ASN B 526 ASN B 543 1 18 HELIX 25 AC7 ASN B 544 PHE B 548 5 5 HELIX 26 AC8 THR B 549 HIS B 563 1 15 HELIX 27 AC9 SER B 571 PHE B 578 1 8 HELIX 28 AD1 HIS B 580 TYR B 586 1 7 HELIX 29 AD2 SER B 589 LEU B 605 1 17 HELIX 30 AD3 SER B 615 THR B 633 1 19 HELIX 31 AD4 LEU B 637 THR B 651 1 15 HELIX 32 AD5 ASN B 658 LEU B 675 1 18 HELIX 33 AD6 CYS B 676 LYS B 680 5 5 HELIX 34 AD7 LEU B 681 LEU B 706 1 26 HELIX 35 AD8 ILE B 711 ASP B 720 5 10 HELIX 36 AD9 GLU B 721 VAL B 733 1 13 HELIX 37 AE1 VAL B 733 LEU B 745 1 13 HELIX 38 AE2 THR B 748 ARG B 767 1 20 LINK NE2 HIS A 529 ZN ZN A 801 1555 1555 2.35 LINK NE2 HIS A 563 ZN ZN A 801 1555 1555 2.32 LINK OD2 ASP A 564 ZN ZN A 801 1555 1555 2.07 LINK OD1 ASP A 564 MG MG A 802 1555 1555 2.26 LINK OD1 ASP A 674 ZN ZN A 801 1555 1555 2.19 LINK ZN ZN A 801 O HOH A 926 1555 1555 2.16 LINK MG MG A 802 O HOH A 918 1555 1555 1.87 LINK MG MG A 802 O HOH A 926 1555 1555 2.31 LINK NE2 HIS B 529 ZN ZN B 801 1555 1555 2.53 LINK NE2 HIS B 563 ZN ZN B 801 1555 1555 2.10 LINK OD2 ASP B 564 ZN ZN B 801 1555 1555 2.08 LINK OD1 ASP B 564 MG MG B 802 1555 1555 2.16 LINK OE2 GLU B 592 MG MG B 802 1555 1555 2.81 LINK OD2 ASP B 674 ZN ZN B 801 1555 1555 1.85 LINK MG MG B 802 O HOH B 916 1555 1555 2.47 SITE 1 AC1 5 HIS A 529 HIS A 563 ASP A 564 ASP A 674 SITE 2 AC1 5 HOH A 926 SITE 1 AC2 3 ASP A 564 HOH A 918 HOH A 926 SITE 1 AC3 9 VAL A 678 ILE A 692 TYR A 693 MET A 713 SITE 2 AC3 9 GLU A 721 GLY A 725 GLN A 726 GLY A 728 SITE 3 AC3 9 PHE A 729 SITE 1 AC4 4 HIS B 529 HIS B 563 ASP B 564 ASP B 674 SITE 1 AC5 4 ASP B 564 GLU B 592 THR B 633 HOH B 916 CRYST1 49.941 81.683 162.493 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020024 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012242 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006154 0.00000